MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
Suggest Documents
Vaccinia from recombinant virus expressing HIV genes.
Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine.
Biological effects of recombinant vaccinia virus-expressed interleukin 4.
A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA).
Direct identification of recombinant vaccinia virus plaques by PCR.
Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus.
Accidental infection of laboratory worker with recombinant vaccinia virus.
Safety of recombinant vaccinia vaccines.
Safety of recombinant vaccinia vaccines.
Intracellular processing of the porcine coronavirus transmissible gastroenteritis virus spike protein expressed by recombinant vaccinia virus.
Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus.
In vivo recognition of orf virus early transcriptional promoters in a vaccinia virus recombinant.
Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization.
Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system.
Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
Rescue of Sindbis virus-specific RNA replication and transcription by using a vaccinia virus recombinant.
Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
A new vaccinia recombinant plasmid pSC-O.
Attenuation of Vaccinia Virus.
Transient dominant selection of recombinant vaccinia viruses.
Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
vaccinia recombinant virus.
Interleukin-2 (IL-2) is a T-cell derived molecule implicated in the clonal expansion of antigen-activated T cells and in T-cell development. IL-2 is a...
517KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Vaccinia from recombinant virus expressing HIV genes.
Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine.
Biological effects of recombinant vaccinia virus-expressed interleukin 4.
A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA).
Direct identification of recombinant vaccinia virus plaques by PCR.
Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus.
Accidental infection of laboratory worker with recombinant vaccinia virus.
Safety of recombinant vaccinia vaccines.
Safety of recombinant vaccinia vaccines.
Intracellular processing of the porcine coronavirus transmissible gastroenteritis virus spike protein expressed by recombinant vaccinia virus.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
